Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy

Cell Transplantation

Volumn 21, Issue 11, 2012, Pages 2425-2439

  Hyun, Young Youl ^a   Kim, In Ok ^b,c   Kim, Mi Hyung ^b   Nam, Deok Hwa ^a   Lee, Mi Hwa ^a   Kim, Jung Eun ^a   Song, Hye Kyoung ^a   Cha, Jin Joo ^a   Kang, Young Sun ^a   Lee, Ji Eun ^d   Kim, Hyun Wook ^d   Han, Jee Young ^e   Cha, Dae Ryong ^a  

^a Korea University College of Medicine   (South Korea)

^b Anterogen Co Ltd   (South Korea)

^c Ewha Womans University   (South Korea)

^d Wonkwang University   (South Korea)

^e Inha University Hospital   (South Korea)

Author keywords

Adipose derived stem cells (ASCs); Glomerulosclerosis; HIGA mice; Proteinuria; Th1 cytokine

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ADIPOCYTES; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULONEPHRITIS, IGA; KIDNEY GLOMERULUS; MICE; MICE, INBRED STRAINS; STEM CELLS; T-LYMPHOCYTES;

MUS;

EID: 84871545311     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X639008     Document Type: Article

References (48)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Asaba, K.; Tojo, A.; Onozato, M. L.; Kinugasa, S.; Miyazaki, H.; Miyashita, K.; Uehara, Y.; Hirata, Y.; Kimura, K.; Goto, A.; Omata, M.; Fujita, T. Long-term renal prognosis of IgA nephropathy with therapeutic trend shifts. Intern. Med. 48:883-890; 2009.
3. Bailey, A. M.; Kapur, S.; Katz, A. J. Characterization of adipose-derived stem cells: An update. Curr. Stem Cell Res. Ther. 5:95-102; 2010.
4. Bi, B.; Schmitt, R.; Israilova, M.; Nishio, H.; Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18:2486-2496; 2007.
5. Cai, L.; Johnstone, B. H.; Cook, T. G.; Liang, Z.; Traktuev, D.; Cornetta, K.; Ingram, D. A.; Rosen, E. D.; March, K. L. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 25:3234-3243; 2007.
6. Cai, L.; Johnstone, B. H.; Cook, T. G.; Tan, J.; Fishbein, M. C.; Chen, P. S.; March, K. L. IFATS collection: Human adipose tissuederived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in con-junction with potent preservation of cardiac function. Stem Cells 27:230-237; 2009.
7. Chao, T. K.; Rifai, A.; Ka, S. M.; Yang, S. M.; Shui, H. A.; Lin, Y. F.; Sytwu, H. K.; Lee, W. H.; Kung, J. T.; Chen, A. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int. 70:283-297; 2006.
8. Chintalacharuvu, S. R.; Emancipator, S. N. The glycosyla-tion of IgA produced by murine B-cells is altered by Th2 cytokines. J. Immunol. 159:2327-2333; 1997.
9. Choi, S. J.; Kim, J. K.; Hwang, S. D. Mesenchymal stem cell therapy for chronic renal failure. Expert Opin. Biol. Ther. 10:1217-1226; 2010.
10. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372; 2006.
11. D'Amico, G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 64:709-727; 1987.
12. Duffield, J. S.; Park, K. M.; Hsiao, L. L.; Kelley, V. R.; Scadden, D. T.; Ichimura, T.; Bonventre, J. V. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J. Clin. Invest. 115:1743-1755; 2005.
13. Ebihara, I.; Hirayama, K.; Yamamoto, S.; Muro, K.; Yamagata, K.; Koyama, A. Th2 predominance at the single-cell level in patients with IgA nephropathy. Nephrol. Dial. Transplant. 16:1783-1789; 2001.
14. Glennie, S.; Soeiro, I.; Dyson, P. J.; Lam, E. W.; Dazzi, F. Bone marrow mesenchymal stem cells induce divi-sion arrest anergy of activated T-cells. Blood 105:2821-2827; 2005.
15. Gomez-Guerrero, C.; Lopez-Armada, M. J.; Gonzalez, E.; Egido, J. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-a and IL-6, and proliferation. J. Immunol. 153:5247-5255; 1994.
16. Harper, S. J.; Allen, A. C.; Pringle, J. H.; Feehally, J. Increased dimeric IgA producing B-cells in the bone mar-row in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J. Clin. Pathol. 49:38-42; 1996.
17. Holdsworth, S. R.; Kitching, A. R.; Tipping, P. G. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 55:1198-1216; 1999.
18. Hong, S. J.; Traktuev, D. O.; March, K. L. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr. Opin. Organ Transplant. 15:86-91; 2010.
19. Hurtado, A.; Johnson, R. J. Hygiene hypothesis and preva-lence of glomerulonephritis. Kidney Int. Suppl. 97:S62-S67; 2005.
20. Hwang, H. S.; Kim, B. S.; Shin, Y. S.; Yoon, H. E.; Song, J. C.; Choi, B. S.; Park, C. W.; Yang, C. W.; Kim, Y. S.; Bang, B. K. Predictors for progression in immunoglobu-lin A nephropathy with significant proteinuria. Nephrology 15:236-241; 2010.
21. Imai, H.; Nakamoto, Y.; Asakura, K.; Miki, K.; Yasuda, T.; Miura, A. B. Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis. Kidney Int. 27:756-761; 1985.
22. Johnson, R. J.; Hurtado, A.; Merszei, J.; Rodriguez-Iturbe, B.; Feng, L. Hypothesis: Dysregulation of immuno-logic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide.Am. J. Kidney Dis. 42:575-581; 2003.
23. Kang, Y. S.; Lee, M. H.; Song, H. K.; Hyun, Y. Y.; Cha, J. J.; Ko, G. J.; Kim, S. H.; Lee, J. E.; Han, J. Y.; Cha, D. R. Aliskiren improves insulin resistance and ameliorates dia-betic vascular complications in db/db mice. Nephrol. Dial. Transplant. 26:1194-1204; 2011.
24. Kobayashi, T.; Tanaka, H.; Kuwana, H.; Inoshita, S.; Teraoka, H.; Sasaki, S.; Terada, Y. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem. Biophys. Res. Commun. 336:585-595; 2005.
25. Kondo, K.; Shintani, S.; Shibata, R.; Murakami, H.; Murakami, R.; Imaizumi, M.; Kitagawa, Y.; Murohara, T. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29:61-66; 2009.
26. Kunter, U.; Rong, S.; Djuric, Z.; Boor, P.; Müller-Newen, G.; Yu, D.; Floege, J. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulo-nephritis. J. Am. Soc. Nephrol. 17:2202-2212; 2006.
27. Lazennec, G.; Jorgensen, C. Concise review: Adult multi-potent stromal cells and cancer: Risk or benefit? Stem Cells 26:1387-1394; 2008.
28. Lim, C. S.; Zheng, S. H.; Kim, Y. S.; Lee, S. G.; Zheng, S. H.; Shin, J. H.; Lim, C. S.; Kim, S.; Lee, J. S.; Lee, D. S.; Kim, Y. S. Th1/Th2 predominance and proinflamma-tory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol. Dial. Transplant. 16:269-275; 2001.
29. Miyawaki, S.; Muso, E.; Takeuchi, E.; Matsushima, H.; Shibata, Y.; Sasayama, S.; Yoshida, H. Selective breed-ing for high serum IgA levels from noninbred ddY mice: Isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76:201-207; 1997.
30. Nie, C.; Yang, D.; Xu, J.; Si, Z.; Jin, X.; Zhang, J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant. 20:205-216; 2011.
31. Okada, H.; Konishi, K.; Nakazato, Y.; Kanno, Y.; Suzuki, H.; Sakaguchi, H.; Saruta, T. Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am. J. Kidney Dis. 23:242-246; 1994.
32. Ramot, Y.; Steiner, M.; Morad, V.; Leibovitch, S.; Amouyal, N.; Cesta, M. F.; Nyska, A. Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells. Nanotoxicology 4:98-105; 2010.
33. Reinders, M. E.; Fibbe, W. E.; Rabelink, T. J. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol. Dial. Transplant. 25:17-24; 2010.
34. Rodriguez, A. M.; Elabd, C.; Amri, E. Z.; Ailhaud, G.; Dani, C. The human adipose tissue is a source of multi potent stem cells. Biochimie 87:125-128; 2005.
35. Romagnani, S. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121-129; 1995.
36. Sakai, H.; Endoh, M.; Tomino, Y.; Nomoto, Y. Increase of IgA specific helper T alpha cells in patients with IgA nephropathy. Clin. Exp. Immunol. 50:77-82; 1982.
37. Sakai, H.; Nomoto, Y.; Arimori, S. Decrease of IgA-specific suppressor T-cell activity in patients with IgA nephropathy. Clin. Exp. Immunol. 38:243-248; 1979.
38. Sanz-Ruiz, R.; Fernández-Santos, E.; Domínguez-Muñoa, M.; Parma, R.; Villa, A.; Fernández, L.; Sánchez, P. L.; Fernández-Avilés, F. Early Translation of Adipose-Derived Cell Therapy for Cardiovascular Disease. Cell Transplant. 18:245-254; 2009.
39. Sonoda, E.; Hitoshi, Y.; Yamaguchi, N.; Ishii, T.; Tominaga, A.; Araki, S.; Takatsu, K. Differential Regulation of IgA production by TGF-b and IL-5: TGF-beta Induces sur-face IgA-positive cells bearing Il-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell. Immunol. 140:158-172; 1992.
40. Suzuki, H.; Suzuki, Y.; Aizawa, M.; Yamanaka, T.; Kihara, M.; Pang, H.; Horikoshi, S.; Tomino, Y. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 72:319-327; 2007.
41. Togel, F.; Hu, Z.; Weiss, K.; Isaac, J.; Lange, C.; Westenfelder, C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 289:F31-F42; 2005.
42. Tomino, Y. IgA nephropathy: Lessons from an animal model, the ddY mouse. J. Nephrol. 21:463-467; 2008.
43. Tomino, Y. Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse. Clin. Exp. Nephrol. 15:1-7; 2011.
44. Traktuev, D. O.; Merfeld-Clauss, S.; Li, J.; Kolonin, M.; Arap, W.; Pasqualini, R.; Johnstone, B. H.; March, K. L. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothe-lial networks. Circ. Res. 102:77-85; 2008.
45. Tsuruga, K.; Oki, E.; Aizawa-Yashiro, T.; Yoshida, H.; Imaizumi, T.; Tanaka, H. Potential Th1/Th2 predominance in children with newly diagnosed IgA nephropathy. Acta Paediatr. 99:1584-1586; 2010.
46. Watorek, E.; Klinger, M. Stem cells in nephrology: Present status and future. Arch. Immunol. Ther. Exp. 54:45-50; 2006.
47. Woo, K. T.; Chan, C. M.; Chin, Y. M.; Choong, H. L.; Tan, H. K.; Foo, M.; Anantharaman, V.; Lee, G. S.; Chiang, G. S.; Tan, P. H.; Lim, C. H.; Tan, C. C.; Lee, E.; Tan, H. B.; Fook-Chong, S.; Lau, Y. K.; Wong, K. S. Global evolution-ary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin. Pract. 116:c337-c346; 2010.
48. Yamamoto, M.; Cui, L.; Johkura, K.; Asanuma, K.; Okouchi, Y.; Ogiwara, N.; Sasaki, K. Branching ducts simi-lar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am. J. Physiol. Renal Physiol. 290:F52-F60; 2006.